TGFBR1*6A/9A polymorphism and cancer risk: A meta-analysis of 13,662 cases and 14,147 controls

Molecular Biology Reports

Volumn 37, Issue 7, 2010, Pages 3227-3232

  Liao, Ru Yan ^a   Mao, Chen ^a   Qiu, Li Xin ^b   Ding, Hong ^c   Chen, Qing ^a   Pan, Hai Feng ^d  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Meta analysis; Polymorphism; Susceptibility; TGFBR1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; PROTEIN SERINE THREONINE KINASE; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; COLON CANCER; COLORECTAL CANCER; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; KIDNEY CANCER; LUNG CANCER; OVARY CANCER; PROSTATE CANCER; SENSITIVITY ANALYSIS; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; META ANALYSIS; NEOPLASM; PUBLISHING; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; PUBLICATION BIAS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 77956953950     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9906-7     Document Type: Article

References (37)

1. I Soerjomataram MW Louwman JG Ribot JA Roukema JW Coebergh 2008 An overview of prognostic factors for long-term survivors of breast cancer Breast Cancer Res Treat 107 309 330 1:CAS:528:DC%2BD1cXht1Sgtrw%3D 10.1007/s10549-007- 9556-1 (Pubitemid 351172108)
2. HE Karim-Kos E De Vries I Soerjomataram V Lemmens S Siesling JW Coebergh 2008 Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s Eur J Cancer 44 1345 1389 10.1016/j.ejca.2007.12.015
3. P Lichtenstein NV Holm PK Verkasalo A Iliadou J Kaprio M Koskenvuo 2000 Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland N Engl J Med 343 78 85 1:STN:280:DC%2BD3czjtFCiug%3D%3D 10.1056/NEJM200007133430201 (Pubitemid 30451850)
4. R Ebner RH Chen L Shum S Lawler TF Zioncheck A Lee 1993 Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor Science 260 1344 1348 1:CAS:528:DyaK3sXltlahs70%3D 10.1126/science. 8388127
5. B Pasche P Kolachana K Nafa J Satagopan YG Chen RS Lo 1999 TbetaR-I (6A) is a candidate tumor susceptibility allele Cancer Res 59 5678 5682 1:CAS:528:DyaK1MXnslyht7Y%3D
6. T Chen EG de Vries H Hollema HA Yegen VF Vellucci HD Strickler 1999 Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma Int J Cancer 82 43 51 1:CAS:528:DyaK1MXksVWgtrY%3D 10.1002/(SICI)1097-0215(19990702)82:1<43::AID-IJC9>3.0.CO;2-0 (Pubitemid 29266105)
7. AA van Tilborg A de Vries EC Zwarthoff 2001 The chromosome 9q genes TGFBR1, TSC1, and ZNF189 are rarely mutated in bladder cancer J Pathol 194 76 80 10.1002/path.860 (Pubitemid 32390451)
8. AM Stefanovska GD Efremov AJ Dimovski D Jasar G Zografski T Josifovski 2001 TbetaR-I(6A) polymorphism is not a tumor susceptibility allele in Macedonian colorectal cancer patients. Correspondence re: B. Pasche et al. Type I TbetaR-I (6A) Is a candidate tumor susceptibility allele. Cancer Res., 58:2727-2732, 1998 Cancer Res 61 8351 8352 1:CAS:528:DC%2BD3MXovVShtrs%3D
9. WS Samowitz K Curtin MF Leppert ML Slattery 2001 Uncommon TGFBRI allele is not associated with increased susceptibility to colon cancer Genes Chromosom Cancer 32 381 383 1:CAS:528:DC%2BD3MXovVKgu7o%3D 10.1002/gcc.1203 (Pubitemid 33055123)
10. SW Baxter DY Choong DM Eccles IG Campbell 2002 Transforming growth factor beta receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer Cancer Epidemiol Biomarkers Prev 11 211 214 1:CAS:528:DC%2BD38XisFags7o%3D
11. T Chen C Jackson B Costello N Singer B Colligan L Douglass 2004 An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder Int J Cancer 112 420 425 1:CAS:528:DC%2BD2cXovVelsrc%3D 10.1002/ijc.20419 (Pubitemid 39390606)
12. V Kaklamani L Baddi D Rosman J Liu N Ellis C Oddoux 2004 No major association between TGFBR1 6A and prostate cancer BMC Genet 5 28 10.1186/1471-2156-5-28 (Pubitemid 41363875)
13. B Pasche VG Kaklamani N Hou T Young A Rademaker P Peterlongo 2004 TGFBR1 6A and cancer: a meta-analysis of 12 case-control studies J Clin Oncol 22 756 758 10.1200/JCO.2004.99.271
14. Q Jin K Hemminki E Grzybowska R Klaes M Söderberg H Zientek 2004 Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers Int J Cancer 112 94 99 1:CAS:528:DC%2BD2cXnvVWlsbk%3D 10.1002/ijc.20370 (Pubitemid 39249496)
15. BK Suarez P Pal CH Jin R Kaushal G Sun L Jin 2005 TGFBR1 6A is not associated with prostate cancer in men of European ancestry Prostate Cancer Prostatic Dis 8 50 53 1:CAS:528:DC%2BD2MXisVShsr0%3D 10.1038/sj.pcan.4500765
16. MA Spillman JM Schildkraut S Halabi P Moorman B Calingaert RC Bentley 2005 Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk Gynecol Oncol 97 543 549 1:CAS:528:DC%2BD2MXjs1CltLo%3D 10.1016/j.ygyno.2005.01.025 (Pubitemid 40614902)
17. VG Kaklamani L Baddi J Liu D Rosman S Phukan C Bradley 2005 Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk Cancer Res 65 3454 3461 1:CAS:528: DC%2BD2MXjt1yrtrg%3D
18. T Chen CR Jackson A Link MP Markey BM Colligan LE Douglass 2006 Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer Clin Cancer Res 12 392 397 1:CAS:528: DC%2BD28XmtlKjsQ%3D%3D 10.1158/1078-0432.CCR-05-1518 (Pubitemid 43166126)
19. HS Feigelson AV Patel WR Diver VL Stevens MJ Thun EE Calle 2006 Transforming growth factor beta receptor type I and transforming growth factor beta1 polymorphisms are not associated with postmenopausal breast cancer Cancer Epidemiol Biomarkers Prev 15 1236 1237 1:CAS:528:DC%2BD28Xls1ehtrw%3D 10.1158/1055-9965.EPI-06-0163
20. W You Z Liu J Zhao M Zheng SY Zheng X Liu 2007 No association between TGFBR1*6A and lung cancer J Thorac Oncol 2 657 659 10.1097/JTO. 0b013e318070ccd7 (Pubitemid 47171789)
21. DG Cox K Penney Q Guo SE Hankinson DJ Hunter 2007 TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study BMC Cancer 7 175 10.1186/1471-2407-7-175 (Pubitemid 350162829)
22. B Song S Margolin J Skoglund X Zhou J Rantala S Picelli 2007 TGFBR1*6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer Br J Cancer 97 1175 1179 1:CAS:528:DC%2BD2sXhtFKktbzP 10.1038/sj.bjc.6603961 (Pubitemid 47586998)
23. J Skoglund B Song J Dalén S Dedorson D Edler F Hjern 2007 Lack of an association between the TGFBR1*6A variant and colorectal cancer risk Clin Cancer Res 13 3748 3752 1:CAS:528:DC%2BD2sXmsFCqu7c%3D 10.1158/1078-0432. CCR-06-2865 (Pubitemid 46955140)
24. J Skoglund Lundin J Vandrovcova B Song X Zhou M Zelada-Hedman B Werelius 2009 TGFBR1 variants TGFBR1*6A and Int7G24A are not associated with an increased familial colorectal cancer risk Br J Cancer 100 1674 1679 1:CAS:528:DC%2BD1MXlslCht7s%3D 10.1038/sj.bjc.6605054
25. A Castillejo N Rothman C Murta-Nascimento N Malats M García-Closas A Gómez-Martínez 2009 TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis Int J Cancer 124 608 613 1:CAS:528:DC%2BD1MXmt1Ggsw%3D%3D 10.1002/ijc.24013
26. Jakubowska A, Gronwald J, Menkiszak J, Górski B, Huzarski T, Byrski T (2009) BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat
27. Colleran G, McInerney N, Rowan A, Barclay E, Jones AM, Curran C (2009) The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer. Breast Cancer Res Treat
28. WG Cochran 1954 The combination of estimates from different experiments Biometrics 10 101 129 10.2307/3001666
29. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 177 188 1:STN:280:DyaL2s7gsVamtA%3D%3D 10.1016/0197-2456(86)90046-2 (Pubitemid 17189972)
30. N Mantel W Haenszel 1959 Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 719 748 1:STN:280:DyaG1M%2FosVOhtQ%3D%3D
31. A Tobias 1999 Assessing the influence of a single study in the meta-analysis estimate Stata Tech Bull 8 15 17
32. M Egger G Davey Smith M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test BMJ 315 629 634 1:STN:280: DyaK2svls1KjtA%3D%3D
33. PM Siegel J Massague 2003 Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer Nat Rev Cancer 3 807 820 1:CAS:528:DC%2BD3sXotVWkt78%3D 10.1038/nrc1208
34. SB Jakowlew 2006 Transforming growth factor-b in cancer metastasis Cancer Metastasis Rev 25 435 457 1:CAS:528:DC%2BD28Xht1yktb3N 10.1007/s10555-006-9006- 2 (Pubitemid 44922360)
35. Y Bian V Kaklamani J Reich B Pasche 2003 TGF-beta signaling alterations in cancer Cancer Treat Res 115 73 94 1:CAS:528:DC%2BD3sXnt12gs7o%3D 10.1007/0-306-48158-8-3
36. E Ziv J Cauley PA Morin R Saiz WS Browner 2001 Association between the T29 - >C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: the study of osteoporotic fractures JAMA 285 2859 2863 1:CAS:528:DC%2BD3MXkvVOntrY%3D 10.1001/jama.285.22.2859
37. LL Marchand CA Haiman D van den Berg LR Wilkens LN Kolonel BE Henderson 2004 T29C polymorphism in the transforming growth factor h1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study Cancer Epidemiol Biomarkers Prev 13 412 415